View Future Growth3-D Matrix 과거 순이익 실적과거 기준 점검 3/63-D Matrix은 연평균 40.5%의 비율로 수입이 증가해 온 반면, Biotechs 산업은 수입이 13.3% 증가했습니다. 매출은 연평균 44.4%의 비율로 증가했습니다. 3-D Matrix의 자기자본이익률은 61.1%이고 순이익률은 38.2%입니다.핵심 정보40.52%순이익 성장률48.15%주당순이익(EPS) 성장률Biotechs 산업 성장률31.91%매출 성장률44.38%자기자본이익률61.13%순이익률38.17%최근 순이익 업데이트30 Apr 2026최근 과거 실적 업데이트분석 기사 • Jun 183-D Matrix's (TSE:7777) Performance Raises Some QuestionsStrong earnings weren't enough to please 3-D Matrix, Ltd.'s ( TSE:7777 ) shareholders over the last week. Our analysis...Reported Earnings • Jun 12Full year 2026 earnings released: EPS: JP¥34.88 (vs JP¥25.20 loss in FY 2025)Full year 2026 results: EPS: JP¥34.88 (up from JP¥25.20 loss in FY 2025). Revenue: JP¥10.9b (up 57% from FY 2025). Net income: JP¥4.16b (up JP¥6.66b from FY 2025). Profit margin: 38% (up from net loss in FY 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.공고 • May 103-D Matrix, Ltd. to Report Fiscal Year 2026 Results on Jun 11, 20263-D Matrix, Ltd. announced that they will report fiscal year 2026 results on Jun 11, 2026Reported Earnings • Mar 13Third quarter 2026 earnings released: EPS: JP¥5.39 (vs JP¥5.66 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.39 (up from JP¥5.66 loss in 3Q 2025). Revenue: JP¥2.54b (up 42% from 3Q 2025). Net income: JP¥653.0m (up JP¥1.24b from 3Q 2025). Profit margin: 26% (up from net loss in 3Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.Reported Earnings • Dec 16Second quarter 2026 earnings released: EPS: JP¥7.96 (vs JP¥0.18 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥7.96 (up from JP¥0.18 loss in 2Q 2025). Revenue: JP¥2.61b (up 46% from 2Q 2025). Net income: JP¥936.0m (up JP¥954.0m from 2Q 2025). Profit margin: 36% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.공고 • Sep 233-D Matrix, Ltd. to Report Q2, 2026 Results on Dec 11, 20253-D Matrix, Ltd. announced that they will report Q2, 2026 results on Dec 11, 2025모든 업데이트 보기Recent updates분석 기사 • Jun 183-D Matrix's (TSE:7777) Performance Raises Some QuestionsStrong earnings weren't enough to please 3-D Matrix, Ltd.'s ( TSE:7777 ) shareholders over the last week. Our analysis...Reported Earnings • Jun 12Full year 2026 earnings released: EPS: JP¥34.88 (vs JP¥25.20 loss in FY 2025)Full year 2026 results: EPS: JP¥34.88 (up from JP¥25.20 loss in FY 2025). Revenue: JP¥10.9b (up 57% from FY 2025). Net income: JP¥4.16b (up JP¥6.66b from FY 2025). Profit margin: 38% (up from net loss in FY 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.공고 • Jun 113-D Matrix, Ltd., Annual General Meeting, Jul 23, 20263-D Matrix, Ltd., Annual General Meeting, Jul 23, 2026.Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to JP¥474, the stock trades at a trailing P/E ratio of 48.7x. Average trailing P/E is 30x in the Biotechs industry in Asia. Total returns to shareholders of 153% over the past three years.공고 • May 103-D Matrix, Ltd. to Report Fiscal Year 2026 Results on Jun 11, 20263-D Matrix, Ltd. announced that they will report fiscal year 2026 results on Jun 11, 2026New Risk • Apr 28New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Shareholders have been diluted in the past year (16% increase in shares outstanding).Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥585, the stock trades at a trailing P/E ratio of 58.7x. Average trailing P/E is 41x in the Biotechs industry in Asia. Total returns to shareholders of 257% over the past three years.Valuation Update With 7 Day Price Move • Mar 19Investor sentiment deteriorates as stock falls 34%After last week's 34% share price decline to JP¥470, the stock trades at a trailing P/E ratio of 46.8x. Average trailing P/E is 37x in the Biotechs industry in Asia. Total returns to shareholders of 106% over the past three years.Reported Earnings • Mar 13Third quarter 2026 earnings released: EPS: JP¥5.39 (vs JP¥5.66 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.39 (up from JP¥5.66 loss in 3Q 2025). Revenue: JP¥2.54b (up 42% from 3Q 2025). Net income: JP¥653.0m (up JP¥1.24b from 3Q 2025). Profit margin: 26% (up from net loss in 3Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.분석 기사 • Jan 163-D Matrix, Ltd.'s (TSE:7777) Price Is Right But Growth Is Lacking After Shares Rocket 46%Despite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 46% in the...New Risk • Dec 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).Reported Earnings • Dec 16Second quarter 2026 earnings released: EPS: JP¥7.96 (vs JP¥0.18 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥7.96 (up from JP¥0.18 loss in 2Q 2025). Revenue: JP¥2.61b (up 46% from 2Q 2025). Net income: JP¥936.0m (up JP¥954.0m from 2Q 2025). Profit margin: 36% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.분석 기사 • Nov 133-D Matrix, Ltd.'s (TSE:7777) Share Price Boosted 27% But Its Business Prospects Need A Lift TooDespite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 27% in the...분석 기사 • Oct 283-D Matrix (TSE:7777) Is Carrying A Fair Bit Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...공고 • Oct 203-D Matrix, Ltd. Announces Collaborative Research with Harvard Drives Regenerative Medicine Breakthrough3-D Matrix, Ltd. has been engaged in the development of medical products based on its proprietary self-assembling peptide technology. In the field of regenerative medicine, the Company has been promoting collaborative research with leading academic institutions worldwide. The company announced that the results of joint research with Harvard University, employing the Company's self-assembling peptide "RADA16," was recently published in the internationally renowned scientific journal Science. This publication marks a advancement in addressing fundamental challenges in cardiac regenerative therapy. Conventional transplantation of iPSC-derived cardiomyocytes has been hindered by the occurrence of life-threatening arrhythmias caused by abnormal automaticity (spontaneous contraction) of the transplanted cells. In this study, the company successfully suppressed this arrhythmogenic automaticity through co-administration of the Company's self- assemblingling peptide. Furthermore, using a technology of flexible nanoelectronics, company were the first in the world to visualize how transplanted cells electrically integrate and synchronize with host cardiac tissue. In addition, the study demonstrated that the peptide significantly accelerated the maturation of the transplanted cells, shifting their gene expression profile from a fetal-like to an adult-like state, and markedly enhanced the organization of sarcomeres, the contractile units of cardiomyocytes. In addition, functional vascularization, which was difficult to verify, was clearly confirmed. The transplanted tissue formed functional anastomoses with host vasculature, establishing a stable supply of oxygen and nutrients, which greatly improved cell survival. This technology is expected not only to accelerate the practical application of iPSC-based therapies for heart disease, but also to drive progress in regenerative medicine for various tissues requiring vascularization. This research was conducted within the existing development budget and will have no impact on full-year financial forecast or current mid-term business plan. The Company will continue to collaborate globally with leading academic institutions to contribute to solving unmet medical needs and to bring new medical value to society through innovation in regenerative medicine.공고 • Sep 233-D Matrix, Ltd. to Report Q2, 2026 Results on Dec 11, 20253-D Matrix, Ltd. announced that they will report Q2, 2026 results on Dec 11, 2025Reported Earnings • Sep 12First quarter 2026 earnings released: EPS: JP¥6.88 (vs JP¥9.20 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥6.88 (up from JP¥9.20 loss in 1Q 2025). Revenue: JP¥2.19b (up 48% from 1Q 2025). Net income: JP¥765.0m (up JP¥1.55b from 1Q 2025). Profit margin: 35% (up from net loss in 1Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.분석 기사 • Aug 013-D Matrix, Ltd. (TSE:7777) Surges 25% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 25% in the...공고 • Jul 113-D Matrix, Ltd. announced that it has received ¥1.103184 billion in funding from CVI Investments, Inc.On July 10, 2025, 3-D Matrix Co., Ltd. closed the transaction.공고 • Jul 093-D Matrix, Ltd. to Report Q1, 2026 Results on Sep 11, 20253-D Matrix, Ltd. announced that they will report Q1, 2026 results on Sep 11, 2025Reported Earnings • Jun 14Full year 2025 earnings released: JP¥25.20 loss per share (vs JP¥3.48 loss in FY 2024)Full year 2025 results: JP¥25.20 loss per share (further deteriorated from JP¥3.48 loss in FY 2024). Revenue: JP¥6.93b (up 51% from FY 2024). Net loss: JP¥2.50b (loss widened JP¥2.25b from FY 2024). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공고 • Jun 123-D Matrix, Ltd., Annual General Meeting, Jul 24, 20253-D Matrix, Ltd., Annual General Meeting, Jul 24, 2025.분석 기사 • Jun 11Improved Revenues Required Before 3-D Matrix, Ltd. (TSE:7777) Stock's 27% Jump Looks Justified3-D Matrix, Ltd. ( TSE:7777 ) shareholders are no doubt pleased to see that the share price has bounced 27% in the last...공고 • Apr 113-D Matrix, Ltd. to Report Fiscal Year 2025 Results on Jun 12, 20253-D Matrix, Ltd. announced that they will report fiscal year 2025 results on Jun 12, 2025분석 기사 • Apr 07Investors Don't See Light At End Of 3-D Matrix, Ltd.'s (TSE:7777) Tunnel And Push Stock Down 32%To the annoyance of some shareholders, 3-D Matrix, Ltd. ( TSE:7777 ) shares are down a considerable 32% in the last...Reported Earnings • Mar 14Third quarter 2025 earnings released: JP¥5.66 loss per share (vs JP¥7.18 loss in 3Q 2024)Third quarter 2025 results: JP¥5.66 loss per share. Revenue: JP¥1.79b (up 56% from 3Q 2024). Net loss: JP¥588.0m (loss widened 5.0% from 3Q 2024).New Risk • Mar 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 37% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.8b free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Shareholders have been substantially diluted in the past year (37% increase in shares outstanding).분석 기사 • Feb 173-D Matrix, Ltd. (TSE:7777) Surges 27% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 27% in the...공고 • Jan 173-D Matrix, Ltd. to Report Q3, 2025 Results on Mar 13, 20253-D Matrix, Ltd. announced that they will report Q3, 2025 results on Mar 13, 2025New Risk • Dec 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.8b free cash flow). Share price has been highly volatile over the past 3 months (7.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (30% increase in shares outstanding). Market cap is less than US$100m (JP¥13.7b market cap, or US$87.4m).분석 기사 • Dec 193-D Matrix, Ltd.'s (TSE:7777) Price Is Right But Growth Is Lacking After Shares Rocket 33%3-D Matrix, Ltd. ( TSE:7777 ) shareholders would be excited to see that the share price has had a great month, posting...New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (JP¥12.6b market cap, or US$82.1m).Reported Earnings • Dec 13Second quarter 2025 earnings released: JP¥0.18 loss per share (vs JP¥2.08 loss in 2Q 2024)Second quarter 2025 results: JP¥0.18 loss per share (improved from JP¥2.08 loss in 2Q 2024). Revenue: JP¥1.79b (up 77% from 2Q 2024). Net loss: JP¥18.0m (loss narrowed 88% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.공고 • Oct 293-D Matrix, Ltd. to Report Q2, 2025 Results on Dec 12, 20243-D Matrix, Ltd. announced that they will report Q2, 2025 results on Dec 12, 2024Reported Earnings • Sep 17First quarter 2025 earnings released: JP¥9.20 loss per share (vs JP¥0.12 profit in 1Q 2024)First quarter 2025 results: JP¥9.20 loss per share (down from JP¥0.12 profit in 1Q 2024). Revenue: JP¥1.49b (up 80% from 1Q 2024). Net loss: JP¥787.0m (down JP¥795.0m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.분석 기사 • Sep 10We Think 3-D Matrix (TSE:7777) Has A Fair Chunk Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...공고 • Aug 033-D Matrix, Ltd. to Report Q1, 2025 Results on Sep 12, 20243-D Matrix, Ltd. announced that they will report Q1, 2025 results on Sep 12, 2024New Risk • Jul 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.9b free cash flow). Share price has been highly volatile over the past 3 months (7.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (34% increase in shares outstanding). Market cap is less than US$100m (JP¥14.2b market cap, or US$92.1m).Reported Earnings • Jun 17Full year 2024 earnings released: JP¥3.48 loss per share (vs JP¥40.62 loss in FY 2023)Full year 2024 results: JP¥3.48 loss per share (improved from JP¥40.62 loss in FY 2023). Revenue: JP¥4.59b (up 98% from FY 2023). Net loss: JP¥255.0m (loss narrowed 90% from FY 2023). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.공고 • Jun 153-D Matrix, Ltd., Annual General Meeting, Jul 25, 20243-D Matrix, Ltd., Annual General Meeting, Jul 25, 2024.분석 기사 • Jun 083-D Matrix, Ltd. (TSE:7777) Doing What It Can To Lift SharesYou may think that with a price-to-sales (or "P/S") ratio of 3.4x 3-D Matrix, Ltd. ( TSE:7777 ) is definitely a stock...공고 • May 173-D Matrix, Ltd. to Report Fiscal Year 2024 Results on Jun 13, 20243-D Matrix, Ltd. announced that they will report fiscal year 2024 results on Jun 13, 2024공고 • Apr 043-D Matrix, Ltd. announced that it has received ¥22.62 million in funding from CVI Investments, Inc.On April 4, 2024, 3-D Matrix, Ltd., closed the transaction.공고 • Mar 203-D Matrix, Ltd. announced that it expects to receive ¥22.62 million in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement to issue 260,000 stock acquisition rights at an issue price of ¥87 per stock acquisition right for the gross proceeds of ¥22,620,000 on March 19, 2024. The transaction will include participation from returning investor, CVI Investments, Inc. The company will issue shares through third-party allotment. The transaction has been approved by the board of directors of the company.Reported Earnings • Mar 14Third quarter 2024 earnings released: JP¥7.18 loss per share (vs JP¥27.66 loss in 3Q 2023)Third quarter 2024 results: JP¥7.18 loss per share (improved from JP¥27.66 loss in 3Q 2023). Revenue: JP¥1.15b (up 100% from 3Q 2023). Net loss: JP¥560.0m (loss narrowed 67% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.공고 • Mar 013-D Matrix, Ltd. to Report Q3, 2024 Results on Mar 13, 20243-D Matrix, Ltd. announced that they will report Q3, 2024 results on Mar 13, 2024분석 기사 • Feb 26Investors Continue Waiting On Sidelines For 3-D Matrix, Ltd. (TSE:7777)You may think that with a price-to-sales (or "P/S") ratio of 3x 3-D Matrix, Ltd. ( TSE:7777 ) is definitely a stock...Reported Earnings • Dec 16Second quarter 2024 earnings released: JP¥2.08 loss per share (vs JP¥2.42 profit in 2Q 2023)Second quarter 2024 results: JP¥2.08 loss per share (down from JP¥2.42 profit in 2Q 2023). Revenue: JP¥1.01b (up 80% from 2Q 2023). Net loss: JP¥147.0m (down 202% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.공고 • Nov 133-D Matrix, Ltd. to Report Q2, 2024 Results on Dec 13, 20233-D Matrix, Ltd. announced that they will report Q2, 2024 results on Dec 13, 2023New Risk • Sep 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -JP¥4.6b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥4.6b free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Shareholders have been diluted in the past year (12% increase in shares outstanding). Market cap is less than US$100m (JP¥10.9b market cap, or US$73.5m).공고 • Sep 023-D Matrix, Ltd. to Report Q1, 2024 Results on Sep 13, 20233-D Matrix, Ltd. announced that they will report Q1, 2024 results on Sep 13, 2023Reported Earnings • Aug 02Full year 2023 earnings released: JP¥40.62 loss per share (vs JP¥37.19 loss in FY 2022)Full year 2023 results: JP¥40.62 loss per share (further deteriorated from JP¥37.19 loss in FY 2022). Revenue: JP¥2.31b (up 54% from FY 2022). Net loss: JP¥2.45b (loss widened 29% from FY 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.New Risk • Jul 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -JP¥4.6b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-JP¥4.6b free cash flow). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (JP¥9.98b market cap, or US$71.6m).New Risk • Jul 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (JP¥10.6b market cap, or US$73.7m).공고 • Jun 163-D Matrix, Ltd., Annual General Meeting, Jul 27, 20233-D Matrix, Ltd., Annual General Meeting, Jul 27, 2023.Reported Earnings • Jun 16Full year 2023 earnings released: JP¥40.62 loss per share (vs JP¥37.19 loss in FY 2022)Full year 2023 results: JP¥40.62 loss per share (further deteriorated from JP¥37.19 loss in FY 2022). Revenue: JP¥2.31b (up 54% from FY 2022). Net loss: JP¥2.45b (loss widened 29% from FY 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.공고 • May 103-D Matrix, Ltd. to Report Fiscal Year 2023 Results on Jun 14, 20233-D Matrix, Ltd. announced that they will report fiscal year 2023 results on Jun 14, 2023Reported Earnings • Mar 18Third quarter 2023 earnings released: JP¥27.66 loss per share (vs JP¥15.16 loss in 3Q 2022)Third quarter 2023 results: JP¥27.66 loss per share (further deteriorated from JP¥15.16 loss in 3Q 2022). Revenue: JP¥574.0m (up 59% from 3Q 2022). Net loss: JP¥1.70b (loss widened 106% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.공고 • Feb 163-D Matrix, Ltd. to Report Q3, 2023 Results on Mar 17, 20233-D Matrix, Ltd. announced that they will report Q3, 2023 results on Mar 17, 2023Reported Earnings • Dec 15Second quarter 2023 earnings released: EPS: JP¥2.42 (vs JP¥9.09 loss in 2Q 2022)Second quarter 2023 results: EPS: JP¥2.42 (up from JP¥9.09 loss in 2Q 2022). Revenue: JP¥561.0m (up 87% from 2Q 2022). Net income: JP¥144.0m (up JP¥589.0m from 2Q 2022). Profit margin: 26% (up from net loss in 2Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent External Director Kazuya Shimamura was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Nov 093-D Matrix, Ltd. to Report Q2, 2023 Results on Dec 13, 20223-D Matrix, Ltd. announced that they will report Q2, 2023 results on Dec 13, 2022공고 • Oct 193-D Matrix, Ltd. announced that it has received ¥2.059835568 billion in funding from CVI Investments, Inc.On October 17, 2022, 3-D Matrix, Ltd. closed the transaction.공고 • Oct 013-D Matrix, Ltd. announced that it expects to receive ¥2.059835568 billion in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement of 6th unsecured convertible bonds, with a face of ¥100 each, at a price of ¥100 per corporate bond for gross proceeds of ¥2,050,000,000 with stock acquisition rights and 55,256 33rd stock acquisition rights at a price of ¥178 for gross proceeds of ¥9,835,568; for an aggregate gross proceeds of ¥2,059,835,568 on September 30, 2022. The transaction will include participation from returning investor CVI Investments, Inc. The funding will be raised through third-party allotment. The bonds will be convertible at an initial conversion price of ¥371 into 5,525,606 shares from October 17, 2025 to April 17, 2026 and matures on October 22, 2026. The bonds carry interest rate of 2%. The bonds are redeemable. The exercise period for 33rd stock acquisition rights is from October 18, 2022 to October 18, 2027. They carry an initial exercise price of ¥371 each. The transaction has been approved by the board of directors of directors. The transaction is expected to close on October 17, 2022.Reported Earnings • Sep 16First quarter 2023 earnings released: JP¥9.24 loss per share (vs JP¥17.54 loss in 1Q 2022)First quarter 2023 results: JP¥9.24 loss per share (improved from JP¥17.54 loss in 1Q 2022). Revenue: JP¥423.0m (up 24% from 1Q 2022). Net loss: JP¥524.0m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 51% p.a. on average during the next 2 years, compared to a 26% growth forecast for the Biotechs industry in Japan. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.공고 • Aug 033-D Matrix, Ltd. to Report Q1, 2023 Results on Sep 14, 20223-D Matrix, Ltd. announced that they will report Q1, 2023 results on Sep 14, 2022Reported Earnings • Aug 03Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: JP¥37.19 loss per share (up from JP¥49.64 loss in FY 2021). Revenue: JP¥1.51b (up 47% from FY 2021). Net loss: JP¥1.89b (loss narrowed 5.9% from FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 29%. Over the next year, revenue is forecast to grow 79%, compared to a 256% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.공고 • Jun 163-D Matrix, Ltd., Annual General Meeting, Jul 28, 20223-D Matrix, Ltd., Annual General Meeting, Jul 28, 2022.Reported Earnings • Jun 15Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: JP¥37.19 loss per share (up from JP¥49.64 loss in FY 2021). Revenue: JP¥1.51b (up 47% from FY 2021). Net loss: JP¥1.89b (loss narrowed 5.9% from FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 29%. Over the next year, revenue is forecast to grow 79%, compared to a 546% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.공고 • May 133-D Matrix, Ltd. to Report Fiscal Year 2022 Results on Jun 14, 20223-D Matrix, Ltd. announced that they will report fiscal year 2022 results on Jun 14, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent External Director Kazuya Shimamura was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Apr 133-D Matrix, Ltd. announced that it expects to receive ¥1.7650936 billion in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement of approximately 17,650,936 5th unsecured convertible bonds, with a face of JPY 100 each, at a price of JPY 100 per corporate bond with 40 units of stock acquisition rights for gross proceeds of JPY 1,765,093,600 and 31st stock acquisition rights on April 11, 2022. The funding will be raised through third-party allotment. The transaction is expected to close on April 27, 2022. The stock acquisition rights will be convertible at a initial conversion price of JPY 441 into 4,002,479 shares. The transaction will include participation from returning investor CVI Investments, Inc. The bonds carry interest rate of 2% and have a redemption date of June 5, 2026. The application period for 31st stock acquisition rights is on April 27, 2022. They carry an initial exercise price of JPY 441 each. The transaction has been approved by the board of directors of directors.Reported Earnings • Mar 16Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: JP¥15.16 loss per share (down from JP¥11.52 loss in 3Q 2021). Revenue: JP¥360.0m (up 55% from 3Q 2021). Net loss: JP¥828.0m (loss widened 73% from 3Q 2021). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 8.2%. Over the next year, revenue is forecast to grow 139%, compared to a 2,909% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.Reported Earnings • Dec 17Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: JP¥9.09 loss per share (up from JP¥16.66 loss in 2Q 2021). Revenue: JP¥300.0m (up 14% from 2Q 2021). Net loss: JP¥445.0m (loss narrowed 35% from 2Q 2021). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 8.2%. Earnings per share (EPS) missed analyst estimates by 8.2%. Over the next year, revenue is forecast to grow 135%, compared to a 3,108% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Reported Earnings • Sep 18First quarter 2022 earnings released: JP¥17.54 loss per share (vs JP¥11.16 loss in 1Q 2021)The company reported a mediocre first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2022 results: Revenue: JP¥340.0m (up 63% from 1Q 2021). Net loss: JP¥797.0m (loss widened 95% from 1Q 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.공고 • Aug 283-D Matrix, Ltd. announced that it has received ¥2.609 billion in funding from CVI Investments, Inc.On August 27, 2021, 3-D Matrix, Ltd. closed the transaction.공고 • Aug 123-D Matrix, Ltd. announced that it expects to receive ¥2.609 billion in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement of approximately 8,000,000 4th unsecured convertible bonds, with a face of JPY 100 each, at a price of JPY 100 per corporate bond with 40 units of stock acquisition rights for gross proceeds of JPY 800,000,000 and 65,000 30th stock acquisition rights for gross proceeds of JPY 14,430,000, for aggregate gross proceeds of JPY 2,609,000 on August 11, 2021. The funding will be raised through third-party allotment. The transaction is expected to close on August 27, 2021. The stock acquisition rights will be convertible at a initial conversion price of JPY 311 into 2,572,347 shares. The transaction will include participation from returning investor CVI Investments, Inc. The bonds carry no interest rate and have a redemption date of October 4, 2025. The application period for 30th stock acquisition rights is from August 30, 2021 to August 29, 2022. They carry an initial exercise price of JPY 280 each. The transaction has been approved by the board of directors of directors.공고 • Aug 053-D Matrix, Ltd. (JASDAQ:7777) signed contract to acquire 10% stake in PURMX Therapeutics Co., Ltd.3-D Matrix, Ltd. (JASDAQ:7777) signed contract to acquire 10% stake in PURMX Therapeutics Co., Ltd. on August 3, 2021. As part of the transaction, 3-D Matrix, Ltd. will transfer patent and license to PURMX Therapeutics Co., Ltd.Reported Earnings • Aug 03Full year 2021 earnings released: JP¥49.64 loss per share (vs JP¥103 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: JP¥1.02b (up 52% from FY 2020). Net loss: JP¥2.01b (loss narrowed 35% from FY 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 18Full year 2021 earnings released: JP¥49.64 loss per share (vs JP¥103 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: JP¥1.02b (up 52% from FY 2020). Net loss: JP¥2.01b (loss narrowed 35% from FY 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.분석 기사 • Apr 223-D Matrix (TYO:7777) Is Carrying A Fair Bit Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Mar 18Third quarter 2021 earnings released: JP¥11.52 loss per share (vs JP¥22.05 loss in 3Q 2020)The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: JP¥233.0m (up 23% from 3Q 2020). Net loss: JP¥479.0m (loss narrowed 28% from 3Q 2020). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.공고 • Mar 073-D Matrix, Ltd. to Report Q3, 2021 Results on Mar 16, 20213-D Matrix, Ltd. announced that they will report Q3, 2021 results on Mar 16, 2021분석 기사 • Feb 233-D Matrix's (TYO:7777) Shareholders Are Down 68% On Their SharesThe truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term 3-D...Is New 90 Day High Low • Dec 25New 90-day low: JP¥280The company is down 32% from its price of JP¥410 on 25 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.Reported Earnings • Dec 17Second quarter 2021 earnings released: JP¥16.66 loss per shareThe company reported a solid second quarter result with improved revenues and control over expenses, though losses increased. Second quarter 2021 results: Revenue: JP¥263.0m (up 50% from 2Q 2020). Net loss: JP¥679.0m (loss widened 6.6% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings.Is New 90 Day High Low • Dec 08New 90-day low: JP¥339The company is down 14% from its price of JP¥395 on 09 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 5.0% over the same period.공고 • Dec 053-D Matrix, Ltd. to Report Q2, 2021 Results on Dec 15, 20203-D Matrix, Ltd. announced that they will report Q2, 2021 results on Dec 15, 2020공고 • Nov 113-D Matrix, Ltd. announced that it expects to receive ¥216.0702 million in funding from CVI Investments, Inc.3-D Matrix, Ltd. (JASDAQ:7777) announced that it has entered into purchase agreement to issue 561,700 shares at issue price of ¥356 per share for gross proceeds of ¥199,965,200, 55,000 27th stock acquisition rights at issue price of ¥291 per right for gross proceeds of ¥16,105,000, 10,000 28th stock acquisition rights at issue price of ¥10 per right for gross proceeds of ¥100,000; for an aggregate gross proceeds of ¥216,170,200 on November 10, 2020. The transaction includes participation from returning investor, CVI Investments, Inc. The company will raise money through third party allotment. The 27th stock acquisition rights can be exercisable to purchase 5,500,000 shares of the company at an exercise price of ¥356 per share and 28th stock acquisition rights can be exercise to purchase 1,000,000 shares of the company at an exercise price of ¥435 per share. The 27th stock acquisition rights can be exercised from November 27, 2020 to May 26, 2022 and 28th stock acquisition rights can be exercised from November 27, 2020 to November 26, 2024. The company incurred issuance expense of ¥25,000,000 in relation to the transaction. The transaction is expected to close on November 26, 2020. The transaction has been approved by the board of directors of the company.Is New 90 Day High Low • Nov 01New 90-day low: JP¥378The company is down 3.0% from its price of JP¥389 on 03 August 2020. The Japanese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 6.0% over the same period.공고 • Sep 043-D Matrix, Ltd. to Report Q1, 2021 Results on Sep 14, 20203-D Matrix, Ltd. announced that they will report Q1, 2021 results on Sep 14, 2020매출 및 비용 세부 내역3-D Matrix가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TSE:7777 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비30 Apr 2610,8864,1556,59664031 Jan 269,2211,2465,77657231 Oct 258,46755,54753031 Jul 257,643-9495,35252530 Apr 256,934-2,5015,08249831 Jan 256,663-9495,27958631 Oct 246,026-9215,05156831 Jul 245,246-1,0504,81755730 Apr 244,588-2554,64755531 Jan 243,740-1,0624,31951431 Oct 233,166-2,2044,17550831 Jul 232,718-1,9134,19844930 Apr 232,314-2,4453,99545131 Jan 232,064-1,9063,71446831 Oct 221,850-1,0323,45254331 Jul 221,589-1,6212,97863830 Apr 221,506-1,8942,71368431 Jan 221,319-2,5162,52775631 Oct 211,192-2,1672,46577531 Jul 211,155-2,4012,31276330 Apr 211,024-2,0122,16878531 Jan 21871-2,5241,95175531 Oct 20828-2,7081,83677031 Jul 20740-2,6661,80082730 Apr 20672-3,0961,84680131 Jan 20641-2,7961,84280631 Oct 19524-2,7991,73178031 Jul 19417-2,7671,61077130 Apr 19328-2,5541,49778631 Jan 19254-2,4811,41974831 Oct 18243-2,3201,44671231 Jul 18214-2,1361,43464530 Apr 18228-1,8661,36356231 Jan 18713-1,4101,39255231 Oct 17689-1,2441,37351231 Jul 17673-1,1991,31646330 Apr 17615-1,3921,28546931 Jan 17138-1,7981,19248131 Oct 16120-2,4531,09253431 Jul 16103-2,5551,10761530 Apr 16141-2,4591,18166131 Jan 16171-2,3311,16469731 Oct 15151-1,7761,23373631 Jul 15145-1,8121,242841양질의 수익: 7777의 비현금 수익 수준이 높습니다.이익 마진 증가: 7777는 과거에 흑자전환했습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 7777는 지난 5년 동안 흑자전환하며 연평균 40.5%의 수익 성장을 기록했습니다.성장 가속화: 7777는 지난해 흑자전환하여 5년 평균과 수익 성장률을 비교하기 어렵습니다.수익 대 산업: 7777는 지난해 흑자전환하여 지난 해 수익 성장률을 Biotechs 업계(4.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 7777의 자본 수익률(61.1%)은 뛰어남으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/17 12:55종가2026/07/17 00:00수익2026/04/30연간 수익2026/04/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스3-D Matrix, Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kiyokazu YamazakiIchiyoshi Research Institute Inc.
분석 기사 • Jun 183-D Matrix's (TSE:7777) Performance Raises Some QuestionsStrong earnings weren't enough to please 3-D Matrix, Ltd.'s ( TSE:7777 ) shareholders over the last week. Our analysis...
Reported Earnings • Jun 12Full year 2026 earnings released: EPS: JP¥34.88 (vs JP¥25.20 loss in FY 2025)Full year 2026 results: EPS: JP¥34.88 (up from JP¥25.20 loss in FY 2025). Revenue: JP¥10.9b (up 57% from FY 2025). Net income: JP¥4.16b (up JP¥6.66b from FY 2025). Profit margin: 38% (up from net loss in FY 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.
공고 • May 103-D Matrix, Ltd. to Report Fiscal Year 2026 Results on Jun 11, 20263-D Matrix, Ltd. announced that they will report fiscal year 2026 results on Jun 11, 2026
Reported Earnings • Mar 13Third quarter 2026 earnings released: EPS: JP¥5.39 (vs JP¥5.66 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.39 (up from JP¥5.66 loss in 3Q 2025). Revenue: JP¥2.54b (up 42% from 3Q 2025). Net income: JP¥653.0m (up JP¥1.24b from 3Q 2025). Profit margin: 26% (up from net loss in 3Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Dec 16Second quarter 2026 earnings released: EPS: JP¥7.96 (vs JP¥0.18 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥7.96 (up from JP¥0.18 loss in 2Q 2025). Revenue: JP¥2.61b (up 46% from 2Q 2025). Net income: JP¥936.0m (up JP¥954.0m from 2Q 2025). Profit margin: 36% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
공고 • Sep 233-D Matrix, Ltd. to Report Q2, 2026 Results on Dec 11, 20253-D Matrix, Ltd. announced that they will report Q2, 2026 results on Dec 11, 2025
분석 기사 • Jun 183-D Matrix's (TSE:7777) Performance Raises Some QuestionsStrong earnings weren't enough to please 3-D Matrix, Ltd.'s ( TSE:7777 ) shareholders over the last week. Our analysis...
Reported Earnings • Jun 12Full year 2026 earnings released: EPS: JP¥34.88 (vs JP¥25.20 loss in FY 2025)Full year 2026 results: EPS: JP¥34.88 (up from JP¥25.20 loss in FY 2025). Revenue: JP¥10.9b (up 57% from FY 2025). Net income: JP¥4.16b (up JP¥6.66b from FY 2025). Profit margin: 38% (up from net loss in FY 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.
공고 • Jun 113-D Matrix, Ltd., Annual General Meeting, Jul 23, 20263-D Matrix, Ltd., Annual General Meeting, Jul 23, 2026.
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to JP¥474, the stock trades at a trailing P/E ratio of 48.7x. Average trailing P/E is 30x in the Biotechs industry in Asia. Total returns to shareholders of 153% over the past three years.
공고 • May 103-D Matrix, Ltd. to Report Fiscal Year 2026 Results on Jun 11, 20263-D Matrix, Ltd. announced that they will report fiscal year 2026 results on Jun 11, 2026
New Risk • Apr 28New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Shareholders have been diluted in the past year (16% increase in shares outstanding).
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥585, the stock trades at a trailing P/E ratio of 58.7x. Average trailing P/E is 41x in the Biotechs industry in Asia. Total returns to shareholders of 257% over the past three years.
Valuation Update With 7 Day Price Move • Mar 19Investor sentiment deteriorates as stock falls 34%After last week's 34% share price decline to JP¥470, the stock trades at a trailing P/E ratio of 46.8x. Average trailing P/E is 37x in the Biotechs industry in Asia. Total returns to shareholders of 106% over the past three years.
Reported Earnings • Mar 13Third quarter 2026 earnings released: EPS: JP¥5.39 (vs JP¥5.66 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.39 (up from JP¥5.66 loss in 3Q 2025). Revenue: JP¥2.54b (up 42% from 3Q 2025). Net income: JP¥653.0m (up JP¥1.24b from 3Q 2025). Profit margin: 26% (up from net loss in 3Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
분석 기사 • Jan 163-D Matrix, Ltd.'s (TSE:7777) Price Is Right But Growth Is Lacking After Shares Rocket 46%Despite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 46% in the...
New Risk • Dec 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding).
Reported Earnings • Dec 16Second quarter 2026 earnings released: EPS: JP¥7.96 (vs JP¥0.18 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥7.96 (up from JP¥0.18 loss in 2Q 2025). Revenue: JP¥2.61b (up 46% from 2Q 2025). Net income: JP¥936.0m (up JP¥954.0m from 2Q 2025). Profit margin: 36% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
분석 기사 • Nov 133-D Matrix, Ltd.'s (TSE:7777) Share Price Boosted 27% But Its Business Prospects Need A Lift TooDespite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 27% in the...
분석 기사 • Oct 283-D Matrix (TSE:7777) Is Carrying A Fair Bit Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
공고 • Oct 203-D Matrix, Ltd. Announces Collaborative Research with Harvard Drives Regenerative Medicine Breakthrough3-D Matrix, Ltd. has been engaged in the development of medical products based on its proprietary self-assembling peptide technology. In the field of regenerative medicine, the Company has been promoting collaborative research with leading academic institutions worldwide. The company announced that the results of joint research with Harvard University, employing the Company's self-assembling peptide "RADA16," was recently published in the internationally renowned scientific journal Science. This publication marks a advancement in addressing fundamental challenges in cardiac regenerative therapy. Conventional transplantation of iPSC-derived cardiomyocytes has been hindered by the occurrence of life-threatening arrhythmias caused by abnormal automaticity (spontaneous contraction) of the transplanted cells. In this study, the company successfully suppressed this arrhythmogenic automaticity through co-administration of the Company's self- assemblingling peptide. Furthermore, using a technology of flexible nanoelectronics, company were the first in the world to visualize how transplanted cells electrically integrate and synchronize with host cardiac tissue. In addition, the study demonstrated that the peptide significantly accelerated the maturation of the transplanted cells, shifting their gene expression profile from a fetal-like to an adult-like state, and markedly enhanced the organization of sarcomeres, the contractile units of cardiomyocytes. In addition, functional vascularization, which was difficult to verify, was clearly confirmed. The transplanted tissue formed functional anastomoses with host vasculature, establishing a stable supply of oxygen and nutrients, which greatly improved cell survival. This technology is expected not only to accelerate the practical application of iPSC-based therapies for heart disease, but also to drive progress in regenerative medicine for various tissues requiring vascularization. This research was conducted within the existing development budget and will have no impact on full-year financial forecast or current mid-term business plan. The Company will continue to collaborate globally with leading academic institutions to contribute to solving unmet medical needs and to bring new medical value to society through innovation in regenerative medicine.
공고 • Sep 233-D Matrix, Ltd. to Report Q2, 2026 Results on Dec 11, 20253-D Matrix, Ltd. announced that they will report Q2, 2026 results on Dec 11, 2025
Reported Earnings • Sep 12First quarter 2026 earnings released: EPS: JP¥6.88 (vs JP¥9.20 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥6.88 (up from JP¥9.20 loss in 1Q 2025). Revenue: JP¥2.19b (up 48% from 1Q 2025). Net income: JP¥765.0m (up JP¥1.55b from 1Q 2025). Profit margin: 35% (up from net loss in 1Q 2025). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
분석 기사 • Aug 013-D Matrix, Ltd. (TSE:7777) Surges 25% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 25% in the...
공고 • Jul 113-D Matrix, Ltd. announced that it has received ¥1.103184 billion in funding from CVI Investments, Inc.On July 10, 2025, 3-D Matrix Co., Ltd. closed the transaction.
공고 • Jul 093-D Matrix, Ltd. to Report Q1, 2026 Results on Sep 11, 20253-D Matrix, Ltd. announced that they will report Q1, 2026 results on Sep 11, 2025
Reported Earnings • Jun 14Full year 2025 earnings released: JP¥25.20 loss per share (vs JP¥3.48 loss in FY 2024)Full year 2025 results: JP¥25.20 loss per share (further deteriorated from JP¥3.48 loss in FY 2024). Revenue: JP¥6.93b (up 51% from FY 2024). Net loss: JP¥2.50b (loss widened JP¥2.25b from FY 2024). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공고 • Jun 123-D Matrix, Ltd., Annual General Meeting, Jul 24, 20253-D Matrix, Ltd., Annual General Meeting, Jul 24, 2025.
분석 기사 • Jun 11Improved Revenues Required Before 3-D Matrix, Ltd. (TSE:7777) Stock's 27% Jump Looks Justified3-D Matrix, Ltd. ( TSE:7777 ) shareholders are no doubt pleased to see that the share price has bounced 27% in the last...
공고 • Apr 113-D Matrix, Ltd. to Report Fiscal Year 2025 Results on Jun 12, 20253-D Matrix, Ltd. announced that they will report fiscal year 2025 results on Jun 12, 2025
분석 기사 • Apr 07Investors Don't See Light At End Of 3-D Matrix, Ltd.'s (TSE:7777) Tunnel And Push Stock Down 32%To the annoyance of some shareholders, 3-D Matrix, Ltd. ( TSE:7777 ) shares are down a considerable 32% in the last...
Reported Earnings • Mar 14Third quarter 2025 earnings released: JP¥5.66 loss per share (vs JP¥7.18 loss in 3Q 2024)Third quarter 2025 results: JP¥5.66 loss per share. Revenue: JP¥1.79b (up 56% from 3Q 2024). Net loss: JP¥588.0m (loss widened 5.0% from 3Q 2024).
New Risk • Mar 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 37% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.8b free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Shareholders have been substantially diluted in the past year (37% increase in shares outstanding).
분석 기사 • Feb 173-D Matrix, Ltd. (TSE:7777) Surges 27% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, 3-D Matrix, Ltd. ( TSE:7777 ) shares have been powering on, with a gain of 27% in the...
공고 • Jan 173-D Matrix, Ltd. to Report Q3, 2025 Results on Mar 13, 20253-D Matrix, Ltd. announced that they will report Q3, 2025 results on Mar 13, 2025
New Risk • Dec 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.8b free cash flow). Share price has been highly volatile over the past 3 months (7.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (30% increase in shares outstanding). Market cap is less than US$100m (JP¥13.7b market cap, or US$87.4m).
분석 기사 • Dec 193-D Matrix, Ltd.'s (TSE:7777) Price Is Right But Growth Is Lacking After Shares Rocket 33%3-D Matrix, Ltd. ( TSE:7777 ) shareholders would be excited to see that the share price has had a great month, posting...
New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (JP¥12.6b market cap, or US$82.1m).
Reported Earnings • Dec 13Second quarter 2025 earnings released: JP¥0.18 loss per share (vs JP¥2.08 loss in 2Q 2024)Second quarter 2025 results: JP¥0.18 loss per share (improved from JP¥2.08 loss in 2Q 2024). Revenue: JP¥1.79b (up 77% from 2Q 2024). Net loss: JP¥18.0m (loss narrowed 88% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.
공고 • Oct 293-D Matrix, Ltd. to Report Q2, 2025 Results on Dec 12, 20243-D Matrix, Ltd. announced that they will report Q2, 2025 results on Dec 12, 2024
Reported Earnings • Sep 17First quarter 2025 earnings released: JP¥9.20 loss per share (vs JP¥0.12 profit in 1Q 2024)First quarter 2025 results: JP¥9.20 loss per share (down from JP¥0.12 profit in 1Q 2024). Revenue: JP¥1.49b (up 80% from 1Q 2024). Net loss: JP¥787.0m (down JP¥795.0m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
분석 기사 • Sep 10We Think 3-D Matrix (TSE:7777) Has A Fair Chunk Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
공고 • Aug 033-D Matrix, Ltd. to Report Q1, 2025 Results on Sep 12, 20243-D Matrix, Ltd. announced that they will report Q1, 2025 results on Sep 12, 2024
New Risk • Jul 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.9b free cash flow). Share price has been highly volatile over the past 3 months (7.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (34% increase in shares outstanding). Market cap is less than US$100m (JP¥14.2b market cap, or US$92.1m).
Reported Earnings • Jun 17Full year 2024 earnings released: JP¥3.48 loss per share (vs JP¥40.62 loss in FY 2023)Full year 2024 results: JP¥3.48 loss per share (improved from JP¥40.62 loss in FY 2023). Revenue: JP¥4.59b (up 98% from FY 2023). Net loss: JP¥255.0m (loss narrowed 90% from FY 2023). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
공고 • Jun 153-D Matrix, Ltd., Annual General Meeting, Jul 25, 20243-D Matrix, Ltd., Annual General Meeting, Jul 25, 2024.
분석 기사 • Jun 083-D Matrix, Ltd. (TSE:7777) Doing What It Can To Lift SharesYou may think that with a price-to-sales (or "P/S") ratio of 3.4x 3-D Matrix, Ltd. ( TSE:7777 ) is definitely a stock...
공고 • May 173-D Matrix, Ltd. to Report Fiscal Year 2024 Results on Jun 13, 20243-D Matrix, Ltd. announced that they will report fiscal year 2024 results on Jun 13, 2024
공고 • Apr 043-D Matrix, Ltd. announced that it has received ¥22.62 million in funding from CVI Investments, Inc.On April 4, 2024, 3-D Matrix, Ltd., closed the transaction.
공고 • Mar 203-D Matrix, Ltd. announced that it expects to receive ¥22.62 million in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement to issue 260,000 stock acquisition rights at an issue price of ¥87 per stock acquisition right for the gross proceeds of ¥22,620,000 on March 19, 2024. The transaction will include participation from returning investor, CVI Investments, Inc. The company will issue shares through third-party allotment. The transaction has been approved by the board of directors of the company.
Reported Earnings • Mar 14Third quarter 2024 earnings released: JP¥7.18 loss per share (vs JP¥27.66 loss in 3Q 2023)Third quarter 2024 results: JP¥7.18 loss per share (improved from JP¥27.66 loss in 3Q 2023). Revenue: JP¥1.15b (up 100% from 3Q 2023). Net loss: JP¥560.0m (loss narrowed 67% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
공고 • Mar 013-D Matrix, Ltd. to Report Q3, 2024 Results on Mar 13, 20243-D Matrix, Ltd. announced that they will report Q3, 2024 results on Mar 13, 2024
분석 기사 • Feb 26Investors Continue Waiting On Sidelines For 3-D Matrix, Ltd. (TSE:7777)You may think that with a price-to-sales (or "P/S") ratio of 3x 3-D Matrix, Ltd. ( TSE:7777 ) is definitely a stock...
Reported Earnings • Dec 16Second quarter 2024 earnings released: JP¥2.08 loss per share (vs JP¥2.42 profit in 2Q 2023)Second quarter 2024 results: JP¥2.08 loss per share (down from JP¥2.42 profit in 2Q 2023). Revenue: JP¥1.01b (up 80% from 2Q 2023). Net loss: JP¥147.0m (down 202% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
공고 • Nov 133-D Matrix, Ltd. to Report Q2, 2024 Results on Dec 13, 20233-D Matrix, Ltd. announced that they will report Q2, 2024 results on Dec 13, 2023
New Risk • Sep 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -JP¥4.6b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥4.6b free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Shareholders have been diluted in the past year (12% increase in shares outstanding). Market cap is less than US$100m (JP¥10.9b market cap, or US$73.5m).
공고 • Sep 023-D Matrix, Ltd. to Report Q1, 2024 Results on Sep 13, 20233-D Matrix, Ltd. announced that they will report Q1, 2024 results on Sep 13, 2023
Reported Earnings • Aug 02Full year 2023 earnings released: JP¥40.62 loss per share (vs JP¥37.19 loss in FY 2022)Full year 2023 results: JP¥40.62 loss per share (further deteriorated from JP¥37.19 loss in FY 2022). Revenue: JP¥2.31b (up 54% from FY 2022). Net loss: JP¥2.45b (loss widened 29% from FY 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
New Risk • Jul 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -JP¥4.6b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-JP¥4.6b free cash flow). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (JP¥9.98b market cap, or US$71.6m).
New Risk • Jul 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (JP¥10.6b market cap, or US$73.7m).
공고 • Jun 163-D Matrix, Ltd., Annual General Meeting, Jul 27, 20233-D Matrix, Ltd., Annual General Meeting, Jul 27, 2023.
Reported Earnings • Jun 16Full year 2023 earnings released: JP¥40.62 loss per share (vs JP¥37.19 loss in FY 2022)Full year 2023 results: JP¥40.62 loss per share (further deteriorated from JP¥37.19 loss in FY 2022). Revenue: JP¥2.31b (up 54% from FY 2022). Net loss: JP¥2.45b (loss widened 29% from FY 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
공고 • May 103-D Matrix, Ltd. to Report Fiscal Year 2023 Results on Jun 14, 20233-D Matrix, Ltd. announced that they will report fiscal year 2023 results on Jun 14, 2023
Reported Earnings • Mar 18Third quarter 2023 earnings released: JP¥27.66 loss per share (vs JP¥15.16 loss in 3Q 2022)Third quarter 2023 results: JP¥27.66 loss per share (further deteriorated from JP¥15.16 loss in 3Q 2022). Revenue: JP¥574.0m (up 59% from 3Q 2022). Net loss: JP¥1.70b (loss widened 106% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
공고 • Feb 163-D Matrix, Ltd. to Report Q3, 2023 Results on Mar 17, 20233-D Matrix, Ltd. announced that they will report Q3, 2023 results on Mar 17, 2023
Reported Earnings • Dec 15Second quarter 2023 earnings released: EPS: JP¥2.42 (vs JP¥9.09 loss in 2Q 2022)Second quarter 2023 results: EPS: JP¥2.42 (up from JP¥9.09 loss in 2Q 2022). Revenue: JP¥561.0m (up 87% from 2Q 2022). Net income: JP¥144.0m (up JP¥589.0m from 2Q 2022). Profit margin: 26% (up from net loss in 2Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent External Director Kazuya Shimamura was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Nov 093-D Matrix, Ltd. to Report Q2, 2023 Results on Dec 13, 20223-D Matrix, Ltd. announced that they will report Q2, 2023 results on Dec 13, 2022
공고 • Oct 193-D Matrix, Ltd. announced that it has received ¥2.059835568 billion in funding from CVI Investments, Inc.On October 17, 2022, 3-D Matrix, Ltd. closed the transaction.
공고 • Oct 013-D Matrix, Ltd. announced that it expects to receive ¥2.059835568 billion in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement of 6th unsecured convertible bonds, with a face of ¥100 each, at a price of ¥100 per corporate bond for gross proceeds of ¥2,050,000,000 with stock acquisition rights and 55,256 33rd stock acquisition rights at a price of ¥178 for gross proceeds of ¥9,835,568; for an aggregate gross proceeds of ¥2,059,835,568 on September 30, 2022. The transaction will include participation from returning investor CVI Investments, Inc. The funding will be raised through third-party allotment. The bonds will be convertible at an initial conversion price of ¥371 into 5,525,606 shares from October 17, 2025 to April 17, 2026 and matures on October 22, 2026. The bonds carry interest rate of 2%. The bonds are redeemable. The exercise period for 33rd stock acquisition rights is from October 18, 2022 to October 18, 2027. They carry an initial exercise price of ¥371 each. The transaction has been approved by the board of directors of directors. The transaction is expected to close on October 17, 2022.
Reported Earnings • Sep 16First quarter 2023 earnings released: JP¥9.24 loss per share (vs JP¥17.54 loss in 1Q 2022)First quarter 2023 results: JP¥9.24 loss per share (improved from JP¥17.54 loss in 1Q 2022). Revenue: JP¥423.0m (up 24% from 1Q 2022). Net loss: JP¥524.0m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 51% p.a. on average during the next 2 years, compared to a 26% growth forecast for the Biotechs industry in Japan. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
공고 • Aug 033-D Matrix, Ltd. to Report Q1, 2023 Results on Sep 14, 20223-D Matrix, Ltd. announced that they will report Q1, 2023 results on Sep 14, 2022
Reported Earnings • Aug 03Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: JP¥37.19 loss per share (up from JP¥49.64 loss in FY 2021). Revenue: JP¥1.51b (up 47% from FY 2021). Net loss: JP¥1.89b (loss narrowed 5.9% from FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 29%. Over the next year, revenue is forecast to grow 79%, compared to a 256% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
공고 • Jun 163-D Matrix, Ltd., Annual General Meeting, Jul 28, 20223-D Matrix, Ltd., Annual General Meeting, Jul 28, 2022.
Reported Earnings • Jun 15Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: JP¥37.19 loss per share (up from JP¥49.64 loss in FY 2021). Revenue: JP¥1.51b (up 47% from FY 2021). Net loss: JP¥1.89b (loss narrowed 5.9% from FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 29%. Over the next year, revenue is forecast to grow 79%, compared to a 546% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
공고 • May 133-D Matrix, Ltd. to Report Fiscal Year 2022 Results on Jun 14, 20223-D Matrix, Ltd. announced that they will report fiscal year 2022 results on Jun 14, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent External Director Kazuya Shimamura was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Apr 133-D Matrix, Ltd. announced that it expects to receive ¥1.7650936 billion in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement of approximately 17,650,936 5th unsecured convertible bonds, with a face of JPY 100 each, at a price of JPY 100 per corporate bond with 40 units of stock acquisition rights for gross proceeds of JPY 1,765,093,600 and 31st stock acquisition rights on April 11, 2022. The funding will be raised through third-party allotment. The transaction is expected to close on April 27, 2022. The stock acquisition rights will be convertible at a initial conversion price of JPY 441 into 4,002,479 shares. The transaction will include participation from returning investor CVI Investments, Inc. The bonds carry interest rate of 2% and have a redemption date of June 5, 2026. The application period for 31st stock acquisition rights is on April 27, 2022. They carry an initial exercise price of JPY 441 each. The transaction has been approved by the board of directors of directors.
Reported Earnings • Mar 16Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: JP¥15.16 loss per share (down from JP¥11.52 loss in 3Q 2021). Revenue: JP¥360.0m (up 55% from 3Q 2021). Net loss: JP¥828.0m (loss widened 73% from 3Q 2021). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 8.2%. Over the next year, revenue is forecast to grow 139%, compared to a 2,909% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.
Reported Earnings • Dec 17Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: JP¥9.09 loss per share (up from JP¥16.66 loss in 2Q 2021). Revenue: JP¥300.0m (up 14% from 2Q 2021). Net loss: JP¥445.0m (loss narrowed 35% from 2Q 2021). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 8.2%. Earnings per share (EPS) missed analyst estimates by 8.2%. Over the next year, revenue is forecast to grow 135%, compared to a 3,108% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Sep 18First quarter 2022 earnings released: JP¥17.54 loss per share (vs JP¥11.16 loss in 1Q 2021)The company reported a mediocre first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2022 results: Revenue: JP¥340.0m (up 63% from 1Q 2021). Net loss: JP¥797.0m (loss widened 95% from 1Q 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
공고 • Aug 283-D Matrix, Ltd. announced that it has received ¥2.609 billion in funding from CVI Investments, Inc.On August 27, 2021, 3-D Matrix, Ltd. closed the transaction.
공고 • Aug 123-D Matrix, Ltd. announced that it expects to receive ¥2.609 billion in funding from CVI Investments, Inc.3-D Matrix, Ltd. announced a private placement of approximately 8,000,000 4th unsecured convertible bonds, with a face of JPY 100 each, at a price of JPY 100 per corporate bond with 40 units of stock acquisition rights for gross proceeds of JPY 800,000,000 and 65,000 30th stock acquisition rights for gross proceeds of JPY 14,430,000, for aggregate gross proceeds of JPY 2,609,000 on August 11, 2021. The funding will be raised through third-party allotment. The transaction is expected to close on August 27, 2021. The stock acquisition rights will be convertible at a initial conversion price of JPY 311 into 2,572,347 shares. The transaction will include participation from returning investor CVI Investments, Inc. The bonds carry no interest rate and have a redemption date of October 4, 2025. The application period for 30th stock acquisition rights is from August 30, 2021 to August 29, 2022. They carry an initial exercise price of JPY 280 each. The transaction has been approved by the board of directors of directors.
공고 • Aug 053-D Matrix, Ltd. (JASDAQ:7777) signed contract to acquire 10% stake in PURMX Therapeutics Co., Ltd.3-D Matrix, Ltd. (JASDAQ:7777) signed contract to acquire 10% stake in PURMX Therapeutics Co., Ltd. on August 3, 2021. As part of the transaction, 3-D Matrix, Ltd. will transfer patent and license to PURMX Therapeutics Co., Ltd.
Reported Earnings • Aug 03Full year 2021 earnings released: JP¥49.64 loss per share (vs JP¥103 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: JP¥1.02b (up 52% from FY 2020). Net loss: JP¥2.01b (loss narrowed 35% from FY 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 18Full year 2021 earnings released: JP¥49.64 loss per share (vs JP¥103 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: JP¥1.02b (up 52% from FY 2020). Net loss: JP¥2.01b (loss narrowed 35% from FY 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
분석 기사 • Apr 223-D Matrix (TYO:7777) Is Carrying A Fair Bit Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Mar 18Third quarter 2021 earnings released: JP¥11.52 loss per share (vs JP¥22.05 loss in 3Q 2020)The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: JP¥233.0m (up 23% from 3Q 2020). Net loss: JP¥479.0m (loss narrowed 28% from 3Q 2020). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
공고 • Mar 073-D Matrix, Ltd. to Report Q3, 2021 Results on Mar 16, 20213-D Matrix, Ltd. announced that they will report Q3, 2021 results on Mar 16, 2021
분석 기사 • Feb 233-D Matrix's (TYO:7777) Shareholders Are Down 68% On Their SharesThe truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term 3-D...
Is New 90 Day High Low • Dec 25New 90-day low: JP¥280The company is down 32% from its price of JP¥410 on 25 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.
Reported Earnings • Dec 17Second quarter 2021 earnings released: JP¥16.66 loss per shareThe company reported a solid second quarter result with improved revenues and control over expenses, though losses increased. Second quarter 2021 results: Revenue: JP¥263.0m (up 50% from 2Q 2020). Net loss: JP¥679.0m (loss widened 6.6% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings.
Is New 90 Day High Low • Dec 08New 90-day low: JP¥339The company is down 14% from its price of JP¥395 on 09 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 5.0% over the same period.
공고 • Dec 053-D Matrix, Ltd. to Report Q2, 2021 Results on Dec 15, 20203-D Matrix, Ltd. announced that they will report Q2, 2021 results on Dec 15, 2020
공고 • Nov 113-D Matrix, Ltd. announced that it expects to receive ¥216.0702 million in funding from CVI Investments, Inc.3-D Matrix, Ltd. (JASDAQ:7777) announced that it has entered into purchase agreement to issue 561,700 shares at issue price of ¥356 per share for gross proceeds of ¥199,965,200, 55,000 27th stock acquisition rights at issue price of ¥291 per right for gross proceeds of ¥16,105,000, 10,000 28th stock acquisition rights at issue price of ¥10 per right for gross proceeds of ¥100,000; for an aggregate gross proceeds of ¥216,170,200 on November 10, 2020. The transaction includes participation from returning investor, CVI Investments, Inc. The company will raise money through third party allotment. The 27th stock acquisition rights can be exercisable to purchase 5,500,000 shares of the company at an exercise price of ¥356 per share and 28th stock acquisition rights can be exercise to purchase 1,000,000 shares of the company at an exercise price of ¥435 per share. The 27th stock acquisition rights can be exercised from November 27, 2020 to May 26, 2022 and 28th stock acquisition rights can be exercised from November 27, 2020 to November 26, 2024. The company incurred issuance expense of ¥25,000,000 in relation to the transaction. The transaction is expected to close on November 26, 2020. The transaction has been approved by the board of directors of the company.
Is New 90 Day High Low • Nov 01New 90-day low: JP¥378The company is down 3.0% from its price of JP¥389 on 03 August 2020. The Japanese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 6.0% over the same period.
공고 • Sep 043-D Matrix, Ltd. to Report Q1, 2021 Results on Sep 14, 20203-D Matrix, Ltd. announced that they will report Q1, 2021 results on Sep 14, 2020